Associations of circulating metabolites with cerebral white matter hyperintensities

White matter hyperintensities (WMH) are the most compelling risk factors of stroke, dementia, and early mortality. We aimed to investigate the associations between WMH and circulating metabolites. We studied up to 8190 individuals from the UK Biobank, who have both measurements of 249 plasma metabolites and WMH volume. Linear regression models were applied in pooled samples, and age‐stratified and sex‐stratified subsamples to estimate the associations between WMH and metabolomic measures. We conducted three analytic models. In the basic model, we identified 45 metabolomic measures associated with WMH after multiple testing correction (p < 0.0022), 15 of which remained significant in additional adjustments, but no metabolites passed the full adjustment in pooled samples. The 15 WMH‐related metabolites were subfractions of various sizes of high‐density lipoprotein (HDL), fatty acids, and glycoprotein acetyls. Among them, one fatty acid metabolite and 12 HDL‐related traits showed significant negative associations with WMH. Higher glycoprotein acetyls were associated with large WMH. Strong age and sex specificities were observed indicating distinct metabolomic features accompany WMH in different samples. More metabolites were identified in males and adults under 50 years old. Circulating metabolites showed remarkably widespread associations with WMH. Population specificities may shed light on the different pertinent implications of WMH.

[1]  T. Lehtimäki,et al.  Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young , 2022, Journal of the American Heart Association.

[2]  M. Kroh,et al.  The Effect of Bariatric Surgery on Circulating Levels of Oxidized Low-Density Lipoproteins Is Apparently Independent of Changes in Body Mass Index: A Systematic Review and Meta-Analysis , 2021, Oxidative medicine and cellular longevity.

[3]  K. Wartolowska,et al.  Blood Pressure Determinants of Cerebral White Matter Hyperintensities and Microstructural Injury: UK Biobank Cohort Study , 2021, Hypertension.

[4]  K. Wartolowska,et al.  Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study , 2020, European heart journal.

[5]  C. Dyck,et al.  Alzheimer's & Dementia: The Journal of the Alzheimer's Association , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  W. M. van der Flier,et al.  Circulating metabolites are associated with brain atrophy and white matter hyperintensities , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[7]  T. Paus,et al.  Thickness of the cerebral cortex shows positive association with blood levels of triacylglycerols carrying 18-carbon fatty acids , 2020, Communications Biology.

[8]  A. Hainsworth,et al.  Association of White Matter Hyperintensities and Cardiovascular Disease , 2020, Circulation. Cardiovascular imaging.

[9]  M. Dichgans,et al.  Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol. , 2020, Brain : a journal of neurology.

[10]  T. Paus,et al.  A variant near DHCR24 associates with microstructural properties of white matter and peripheral lipid metabolism in adolescents , 2020, Molecular Psychiatry.

[11]  B. Nordestgaard,et al.  Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study. , 2019, Journal of the American College of Cardiology.

[12]  C. Jack,et al.  Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging. , 2019, Stroke.

[13]  M. Dichgans,et al.  Small vessel disease: mechanisms and clinical implications , 2019, The Lancet Neurology.

[14]  C. Jack,et al.  Plasma Metabolites Associated with Brain MRI Measures of Neurodegeneration in Older Adults in the Atherosclerosis Risk in Communities–Neurocognitive Study (ARIC-NCS) , 2019, International journal of molecular sciences.

[15]  N. Stachenfeld,et al.  Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. , 2018, American journal of physiology. Heart and circulatory physiology.

[16]  T. Paus,et al.  Visceral fat-related systemic inflammation and the adolescent brain: a mediating role of circulating glycerophosphocholines , 2018, International Journal of Obesity.

[17]  V. Salomaa,et al.  Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer’s disease: A prospective study in eight cohorts , 2018, Alzheimer's & Dementia.

[18]  Kenneth J. Smith,et al.  Understanding a role for hypoxia in lesion formation and location in the deep and periventricular white matter in small vessel disease and multiple sclerosis. , 2017, Clinical science.

[19]  Michael W. Weiner,et al.  Metabolic network failures in Alzheimer's disease: A biochemical road map , 2017, Alzheimer's & Dementia.

[20]  Cathie Sudlow,et al.  UK Biobank: opportunities for cardiovascular research , 2017, European heart journal.

[21]  Debbie A Lawlor,et al.  Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies , 2017, American journal of epidemiology.

[22]  Ludovica Griffanti,et al.  Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank , 2017, NeuroImage.

[23]  Paul M. Thompson,et al.  Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults , 2016, Neurobiology of Aging.

[24]  P. Matthews,et al.  Multimodal population brain imaging in the UK Biobank prospective epidemiological study , 2016, Nature Neuroscience.

[25]  Tom R. Gaunt,et al.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. , 2015, Circulation.

[26]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[27]  Pasi Soininen,et al.  Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.

[28]  Carole Dufouil,et al.  Plasma lipids and cerebral small vessel disease , 2014, Neurology.

[29]  D. Rader,et al.  HDL and cardiovascular disease , 2014, The Lancet.

[30]  N. Paynter,et al.  High-Density Lipoprotein Particle Subclass Heterogeneity and Incident Coronary Heart Disease , 2014, Circulation. Cardiovascular quality and outcomes.

[31]  Victoria J. Williams,et al.  Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults , 2013, Human brain mapping.

[32]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[33]  A. Kontush,et al.  Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.

[34]  R. Skoff,et al.  Sexual dimorphism in the white matter of rodents , 2009, Journal of the Neurological Sciences.

[35]  M. van Buchem,et al.  Different progression rates for deep white matter hyperintensities in elderly men and women , 2004, Neurology.

[36]  R. Krauss,et al.  Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. , 2001, The American journal of medicine.

[37]  M. Maletic-Savatic,et al.  Metabolomics of neurodegenerative diseases. , 2015, International review of neurobiology.